C07C51/367

Processes for preparing ACC inhibitors and solid forms thereof

The present disclosure provides solid forms, including a salt or co-crystal, of Compound I: ##STR00001##
which exhibits Acetyl-CoA carboxylase (ACC) inhibitory activity and may be useful in treating ACC mediated diseases. Also provided herein are processes or steps for the preparation of a Compound I and intermediates useful for the processes or steps described herein.

Processes for preparing ACC inhibitors and solid forms thereof

The present disclosure provides solid forms, including a salt or co-crystal, of Compound I: ##STR00001##
which exhibits Acetyl-CoA carboxylase (ACC) inhibitory activity and may be useful in treating ACC mediated diseases. Also provided herein are processes or steps for the preparation of a Compound I and intermediates useful for the processes or steps described herein.

Method for producing 4,4,7-trifluoro-1,2,3,4-tetrahydro-5H-1-benzazepine compound and intermediate used in the method

The present invention provides a method for producing a 4,4,7-trifluoro-1,2,3,4-tetrahydro-5H-1-benzazepine compound which has an superior agonistic activity to an arginine vasopressin V2 receptor and is useful as an active ingredient for a pharmaceutical composition for preventing and/or treating urinary frequency, urinary incontinence, enuresis, central diabetes insipidus, nocturia, nocturnal enuresis, or the like; and useful intermediates for use in the methods. The production method of the present invention is suitable for the industrial production of a medicament, because of a smaller number of steps, a higher yield, and a lower cost, as compared with the methods in the related art.

Method for producing 4,4,7-trifluoro-1,2,3,4-tetrahydro-5H-1-benzazepine compound and intermediate used in the method

The present invention provides a method for producing a 4,4,7-trifluoro-1,2,3,4-tetrahydro-5H-1-benzazepine compound which has an superior agonistic activity to an arginine vasopressin V2 receptor and is useful as an active ingredient for a pharmaceutical composition for preventing and/or treating urinary frequency, urinary incontinence, enuresis, central diabetes insipidus, nocturia, nocturnal enuresis, or the like; and useful intermediates for use in the methods. The production method of the present invention is suitable for the industrial production of a medicament, because of a smaller number of steps, a higher yield, and a lower cost, as compared with the methods in the related art.

A TAUTOMERIC LIGAND ENABLES BIOMIMETIC C-H HYDROXYLATION WITH MOLECULAR OXYGEN
20240059656 · 2024-02-22 ·

Disclosed herein is a process for making a compound of formula (2) by (hetero)aromatic CH hydroxylation of a compound of formula (1): catalyzed by palladium(II) and a bidentate ligand in the presence of O.sub.2. The process is useful for instance, in the late-stage modification of medicinally important heterocycles.

##STR00001##

A TAUTOMERIC LIGAND ENABLES BIOMIMETIC C-H HYDROXYLATION WITH MOLECULAR OXYGEN
20240059656 · 2024-02-22 ·

Disclosed herein is a process for making a compound of formula (2) by (hetero)aromatic CH hydroxylation of a compound of formula (1): catalyzed by palladium(II) and a bidentate ligand in the presence of O.sub.2. The process is useful for instance, in the late-stage modification of medicinally important heterocycles.

##STR00001##

METHOD FOR PRODUCING GLYCOLIC ACID

A method for producing glycolic acid includes selectively hydrogenating glyoxylic acid using a catalyst comprising at least one transition metal element, the glycolic acid produced, which has a bio-based carbon content of above 50%. A method for preparing a composition selected from the group consisting of cosmetics, home care products, personal care products, textiles, food, beverages, drugs, fragrances, inks, or paints includes adding the glycolic acid to the composition.

METHOD FOR PRODUCING GLYCOLIC ACID

A method for producing glycolic acid includes selectively hydrogenating glyoxylic acid using a catalyst comprising at least one transition metal element, the glycolic acid produced, which has a bio-based carbon content of above 50%. A method for preparing a composition selected from the group consisting of cosmetics, home care products, personal care products, textiles, food, beverages, drugs, fragrances, inks, or paints includes adding the glycolic acid to the composition.

METHOD FOR PRODUCING GLYCOLIC ACID

A method for producing glycolic acid includes selectively hydrogenating glyoxylic acid using a catalyst comprising at least one transition metal element, the glycolic acid produced, which has a bio-based carbon content of above 50%. A method for preparing a composition selected from the group consisting of cosmetics, home care products, personal care products, textiles, food, beverages, drugs, fragrances, inks, or paints includes adding the glycolic acid to the composition.

UPGRADING LIGNOCELLULOSIC OR CARBOHYDRATE MATERIAL

The present disclosure relates to a method for upgrading lignocellulosic material carbohydrates and/or carbohydrate derivatives by dimerisation and/or oligomerisation using specific catalysts and to the use of the upgraded products.